Among patients with NSCLC, the presence of liver, bone, lymph node, or adrenal gland metastasis showed a mild trend of positive association with higher ctDNA tumor fractions ( Fig. 2E ).
← all excerpts
Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid Tumors.
1
—
—